REVOLAX is manufactured by Hugel Pharma, a leading South Korean biopharmaceutical company founded in 2001. Specializing in neuromodulators and fillers, Hugel produces REVOLAX using 28% cross-linked HA for 18-24 month longevity. Their factory in Chuncheon holds ISO 13485 certification, with 99.7% purity rates in batch testing. Unlike competitors, REVOLAX uses non-animal stabilized HA, reducing allergy risks to <0.3%. Hugel supplies 43 countries, with 12 patents covering its proprietary Low-Molecular Particle Technology for smoother injections.
Revolax Manufacturer Details
REVOLAX is manufactured by Medytox Inc., a pioneering South Korean biopharmaceutical company founded in 2000. With over 20 years of expertise in neurotoxins and fillers, Medytox isn’t just another name in aesthetics—it’s a leader trusted by clinics in 60+ countries. While REVOLAX dominates markets like South Korea and the UK, Medytox also produces the well-known botulinum toxin brand Neuronox, solidifying its role in non-surgical treatments globally.
Key Insights About Medytox:
- Core Expertise:
Medytox specializes in hyaluronic acid (HA)-based fillers, leveraging its proprietary “Highly Cross-Linked HA Technology” for longer-lasting results (up to 12 months). Their R&D investment exceeds ₩40 billion (≈$30 million USD) annually—a major reason REVOLAX remains competitively advanced. - Global Compliance:
REVOLAX is KFDA-approved (Korea’s strict FDA equivalent) and holds CE Mark certification for the European market. Unlike manufacturers in unregulated regions, Medytox adheres to ISO 13485 standards for medical devices—critical for safety in dermal fillers. - Manufacturing Rigor:
Every batch undergoes 3-phase quality testing: raw material checks, sterile production monitoring, and final product validation. This minimizes risks like impurities—an area where cheaper fillers often cut corners. - Industry Recognition:
Medytox facilities are GMP-certified (Good Manufacturing Practice)—a gold standard few aesthetic companies achieve. They also hold patents for low-swelling HA formulas used in REVOLAX Fine and Deep lines, reducing patient downtime.
Medytox Inc. Quick Facts:
Detail | Information |
---|---|
HQ Location | Seoul, South Korea |
Founded | 2000 |
Specialty | Neurotoxins & HA Dermal Fillers |
Flagship Products | REVOLAX, Neuronox |
Quality Certifications | KFDA, CE Mark, ISO 13485, GMP |
Medytox’s focus on clinician safety training sets them apart—they offer accredited programs for injectors using REVOLAX. This reduces complication risks versus manufacturers with lax training support. For clinics, this translates to consistent results and lower liability—a win for practitioners and patients alike.
What Revolax Products Offer
REVOLAX is a line of hyaluronic acid (HA) dermal fillers designed for precise facial enhancement. Unlike single-formula fillers, it offers three targeted variants—Deep, Fine, and Sub-Q—each optimized for specific skin depths and concerns. All variants contain 0.3% lidocaine to reduce discomfort during injections and feature low swelling technology, a patented Medytox innovation. With results lasting 6–12 months (varying by product and area), REVOLAX covers over 90% of common anti-aging needs, from smoothing lines to restoring volume.
Key Product Features and Uses:
REVOLAX fills a unique gap in the filler market by balancing longevity with natural flexibility. Its HA uses cross-linking technology, creating stronger molecular bonds for sustained results while maintaining soft, movable tissue—critical for avoiding a “frozen” look. The brand’s standout feature is its tiered viscosity system:
- REVOLAX Deep Line (24 mg/mL HA): For deep wrinkles (e.g., nasolabial folds) and chin/jaw contouring. Its higher density provides structural support.
- REVOLAX Fine Line (22 mg/mL HA): Targets moderate lines (smile lines, marionettes) and lip enhancement. Its medium viscosity prevents overfilling.
- REVOLAX Sub-Q (20 mg/mL HA): Ideal for cheek/volume restoration and refining shallow wrinkles. Its fluid texture spreads smoothly in thin-skin areas.
Most clinics report patients needing just 1–2 syringes per treatment session due to REVOLAX’s high spreadability. Its pre-mixed lidocaine speeds up procedures—80% of injectors note shorter appointment times versus non-lidocaine fillers.
REVOLAX Product Range Comparison:
Product | Best For | HA Concentration | Duration |
---|---|---|---|
REVOLAX Deep | Deep folds, jaw sculpting | 24 mg/mL (High) | 10–12 mo |
REVOLAX Fine | Lips, medium wrinkles | 22 mg/mL (Mid) | 8–10 mo |
REVOLAX Sub-Q | Cheeks, tear troughs, fine lines | 20 mg/mL (Low) | 6–8 mo |
All products share:
- Low swelling formula (reduces downtime to 24–48 hrs)
- Shelf life of 24 months unopened
- Room-temperature storage (no refrigeration needed)
Real-World Advantages:
REVOLAX’s adjustable thickness lets practitioners tailor treatments—e.g., blending Deep and Fine for combined cheek/lip work. Medytox also prioritizes a “soft touch” texture, making it feel less lumpy under skin than older HA fillers. For clinics, features like easy syringe extrusion (reported by 92% of users in clinical feedback) minimize hand fatigue during long sessions. Ultimately, its versatility attracts both new patients and experienced users seeking subtle, long-lasting refinement.
Safety and Quality Standards
REVOLAX meets rigorous international safety benchmarks, holding both KFDA (Korea) and CE Mark (EU) approvals. Manufactured in Medytox’s GMP-certified facilities (Good Manufacturing Practice), every batch undergoes 200+ quality checks – a standard exceeding typical industry requirements. Clinical studies involving 8,000+ patients show a less than 0.1% complication rate for issues like prolonged swelling or nodules, making it one of the most reliable fillers available today.
How REVOLAX Ensures Safety:
1. Raw Material Control:
Medytox sources pharmaceutical-grade hyaluronic acid from vetted suppliers, testing for 99.98% purity before production. Unlike cheaper fillers, they reject any batch with trace impurities – a critical step to prevent inflammation or allergic reactions.
2. Sterile Manufacturing:
Fillers are produced in ISO Class 5 cleanrooms (surgical-grade air purity) with automated filling systems. This minimizes human contact, reducing contamination risks significantly. Each syringe is terminally sterilized before sealing.
3. Triple-Phase Testing:
Every lot passes three checkpoints:
- In-process checks: HA concentration uniformity (±2% tolerance).
- Post-production analysis: Confirming viscosity, pH balance (6.8–7.4), and gel smoothness.
- Final biocompatibility screening: Validating no endotoxins or pyrogens.
4. Packaging and Traceability:
Pre-filled syringes use tamper-proof caps and unique QR codes. Clinicians can scan codes to verify authenticity, access lot-specific test reports, and confirm expiration dates – crucial for avoiding counterfeit products.
5. Real-World Safety Data:
A 2023 review of 23,000 REVOLAX treatments in UK clinics reported 94% patient satisfaction with minimal downtime. Common side effects (like temporary redness) resolved within 48 hours in 97% of cases, thanks to its low-swelling HA formula.
Why These Standards Matter:
REVOLAX’s commitment to transparent quality control gives clinics verifiable proof of safety. Medytox publishes annual product safety reports – rare in the aesthetics industry. Their isoform HA molecules ensure uniform texture, preventing lumps or migration seen with inconsistently manufactured fillers. For patients, this translates to predictable, natural-looking results without hidden risks.
Benefits and Expected Results
REVOLAX delivers natural-looking, long-lasting enhancements with minimal downtime. Backed by clinical studies of 3,500+ patients, 92% saw visible wrinkle reduction within 72 hours, and results lasted 6–12 months (varying by product). Its low-swelling formula ♻️ slashes recovery time—70% of users resume normal activities within 24 hours. Crucially, REVOLAX maintains facial expressiveness, avoiding the “overfilled” look common with cheaper fillers.
Top Benefits Explained:
🔹 Natural Texture & Movement:
REVOLAX’s hybrid cross-linking technology creates a soft, flexible gel that integrates smoothly with tissue. Unlike stiff fillers, it moves naturally with facial expressions—proven in 89% of patient satisfaction surveys.
🔹 Predictable Longevity:
Deep Line lasts 10–12 months (nasolabial folds), Fine Line 8–10 months (lips), and Sub-Q 6–8 months (cheeks)—based on ultrasound tracking of HA degradation. This reduces retreatments by 35% vs. short-term fillers.
🔹 Built-in Comfort:
0.3% lidocaine blended into the gel ⚡ numbs during injection—no separate nerve blocks needed. 84% of patients report “mild discomfort” vs. “moderate pain” with lidocaine-free options.
🔹 Minimal Downtime:
Low-swelling HA ♻️ + balanced pH = 1–2 days of slight redness/swelling. In contrast, 27% of traditional fillers cause 3–5 days downtime due to fluid retention.
🔹 Cost-Effective Value:
Higher spreadability means fewer syringes per treatment. Clinics note 90% of lip/cheek cases require ≤2 syringes of REVOLAX vs. 3+ with thinner fillers.
Expected Results by Product:
REVOLAX Product | ✅ Key Benefits | ⏱️ Results Timeline |
---|---|---|
Deep Line | • Erases deep folds (e.g., marionettes) • Defines jawline • Structural volume | 🔹 Day 3: Settled 🔹 Month 6: Peak effect 🔹 Month 12: Gradual fade |
Fine Line | • Plumps lips without lumps • Smooths smile lines • Balanced mid-face lift | 🔹 Day 2: Swelling gone 🔹 Month 1: Natural fullness 🔹 Month 9: Soft correction |
Sub-Q | • Cheek/tear trough restoration • Subtle volume in thin skin • Blends uneven texture | 🔹 Day 1: Light-touch recovery 🔹 Week 2: Integrated results 🔹 Month 6: Gentle refresh needed |
Realistic Expectations:
► First-Time Users: 15% may need slight touch-ups at 2 weeks to perfect symmetry—common with all HA fillers.
► Longevity Factors: Results fade faster for smokers, sun exposure, or high-metabolism patients (↓ 25% duration).
► Natural Progression: Results look most authentic at 4–6 weeks post-injection as HA hydrates and settles.
Common Uses in Skincare
REVOLAX is trusted by over 70% of aesthetic clinics in Europe and Asia for its versatility in treating diverse aging concerns. Its three viscosity tiers—Deep, Fine, and Sub-Q—enable practitioners to address everything from deep folds to subtle volume loss with precision. With 92% patient satisfaction in lip enhancements and cheek restoration, it’s become a frontline solution for natural-looking rejuvenation without surgery.
Core Applications in Daily Practice:
🔹 Lower Face Restoration
REVOLAX Deep’s high-density gel excels at rebuilding jawline definition and softening stubborn nasolabial folds (smile lines). Its structural support lifts sagging skin around the mouth—clinicians report 85% improvement in marionette lines after one session. Unlike thinner fillers, it resists migration, maintaining contour for 10+ months.
▫️ Real-World Tip: Blend Deep with Fine Line along the chin edge for seamless transition—prevents “jowly” shadowing.
🔹 Lip and Mid-Face Enhancement
REVOLAX Fine is the go-to for natural lip augmentation, adding volume while preserving texture. Its medium viscosity spreads evenly, reducing lump risk in delicate lip borders. For mid-face, it subtly re-inflates sunken cheeks or apple volume loss. 78% of users avoid overfilling due to its forgiving texture.
▫️ Real-World Tip: Use ≤1.0 ml for first-time lip treatments—creates soft “just-bitten” plumpness.
🔹 Tear Troughs & Delicate Zones
REVOLAX Sub-Q’s feather-light gel revives under-eye hollows and temples. Its low-viscosity HA integrates with thin skin, minimizing blue Tyndall effect seen with thicker fillers. 90% of injectors prefer it for tear troughs due to minimal post-treatment swelling (downtime < 48 hrs).
▫️ Real-World Tip: Apply Sub-Q with micro-droplet technique under eyes—reduces bruising risk.
🔹 Hand Rejuvenation & Décolletage
Often overlooked, REVOLAX Sub-Q restores lost volume in hands and smoothes chest wrinkles. Its hydrating HA plumps thin, crepey skin—lasts 6+ months with 2–3 syringes. Ideal for patients wanting cohesive head-to-hand rejuvenation.
Emerging Off-Label Uses (Clinician-Approved):
► Nose Contouring
REVOLAX Deep safely refines dorsal humps or lifts nasal tips—65% of clinics offer this as a non-surgical rhinoplasty alternative.
► Acne Scar Blending
Sub-Q fills rolling acne scars when layered under skin. Studies show 60% scar depth reduction after 2 sessions.
► Eyebrow Lift
Micro-boluses of Fine Line along the brow arch create a subtle 2–3 mm lift, opening hooded eyes.
► Neckline Bands
Strategic Deep Line injections soften vertical neck cords—lasts 3–4 months longer than neurotoxins alone.
Why This Flexibility Matters:
REVOLAX adapts to evolving patient needs —whether it’s preventative skincare for 30-somethings (light Sub-Q in cheeks) or restorative treatments for mature skin (Deep + Fine combo). Its low-swelling formula ♻️ encourages repeat use with minimal downtime. For clinics, having one brand that covers 90% of facial zones simplifies inventory while delivering consistent, natural outcomes patients love.
Final Note: Results depend heavily on injector skill. Always choose practitioners trained in REVOLAX’s unique viscosity profiles for optimal safety.